×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Glenmark Pharma
Glenmark Pharma
Ads
Glenmark signs cancer drug licensing deal with China's Hengrui for $18 million upfront with $1.1 billion in milestone payments
Glenmark shares higher as subsidiary gets $700 million from NYSE-listed AbbVie in licensing deal
Chartist Talk: SBI Securities’ Sudeep Shah picks Swiggy; RBL Bank, Glenmark Pharma set for fresh upmove
Glenmark shares rally over 2.5 percent on muti-nation Phase 3 trial for cancer drug Envafolimab
Trade Spotlight: How should you trade Coal India, ITC Hotels, GMDC, Pondy Oxides, Paytm, Glenmark Pharma, HDFC Bank, and others on September 04?
Buy Glenmark Pharma; target of Rs 2400: Motilal Oswal
Glenmark Pharma shares fall 4% as Q1 earnings show fails to impress
Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports
Gainers & Losers: Top 10 stocks that moved the most on July 11
Buy Glenmark Pharma; target of Rs 2430: Motilal Oswal
Mutual funds trump retail in Glenmark surge as cancer drug deal sends stock soaring
Glenmark Pharma shares rally 15% to record high after mega licensing deal for its cancer drug
Glenmark arm IGI licenses cancer drug to AbbVie for upfront $700 mn with $1.22 bn in milestone payment
Chartist Talks: Sudeep Shah of SBI Securities explains why he is bullish on these 6 stocks but flags Glenmark Pharma as overbought
Trade Spotlight: How should you trade Eicher Motors, DMart, Indus Towers, Chambal Fertilisers, MCX India, BHEL, CDSL, and others on June 24?
Trade Spotlight: How should you trade Persistent Systems, Glenmark Pharma, Eternal, Jindal Stainless, L&T Finance, United Spirits and others on June 9?
Buy Glenmark Pharma; target of Rs 1690: Motilal Oswal
Glenmark Standalone March 2025 Net Sales at Rs 2,009.49 crore, down 6.46% Y-o-Y
Glenmark Pharma shares drop 3% on lower-than-expected Q4 results: Should you buy, sell, hold?
Chartist Talks: In April, ICICI Securities' Dharmesh Shah sees Nifty at 24,200, bets on these 3 stock ideas
Trade Spotlight: How should you trade Mazagon Dock, United Spirits, Adani Energy Solutions, Paytm, Glenmark Pharma, and others on March 28?
Trade Spotlight: How should you trade Mazagon Dock, Waaree Energies, Glenmark Pharma, Quess Corp, HPCL, and others on March 24?
Glenmark Consolidated December 2024 Net Sales at Rs 3,387.55 crore, up 35.14% Y-o-Y
Stocks to Watch Today: Alembic Pharma, BHEL, Zydus Life, Zen Technologies, Ajax Engineering, Utkarsh SFB, Glenmark in focus on 17 February
Stocks On Radar: BEL, Glenmark Pharma, Vedanta, Cipla, LIC and more | February 10
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio